WO2001020004A3 - Protein phosphatase and kinase proteins - Google Patents

Protein phosphatase and kinase proteins Download PDF

Info

Publication number
WO2001020004A3
WO2001020004A3 PCT/US2000/025515 US0025515W WO0120004A3 WO 2001020004 A3 WO2001020004 A3 WO 2001020004A3 US 0025515 W US0025515 W US 0025515W WO 0120004 A3 WO0120004 A3 WO 0120004A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein phosphatase
kinase proteins
pphkp
provides
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/025515
Other languages
French (fr)
Other versions
WO2001020004A2 (en
Inventor
Henry Yue
Y Tom Tang
Olga Bandman
Jennifer L Hillman
Mariah R Baughn
Yalda Azimzai
Dyung Aina M Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to JP2001523775A priority Critical patent/JP2003509053A/en
Priority to EP00968368A priority patent/EP1212436A2/en
Priority to CA002383927A priority patent/CA2383927A1/en
Priority to AU78297/00A priority patent/AU7829700A/en
Publication of WO2001020004A2 publication Critical patent/WO2001020004A2/en
Publication of WO2001020004A3 publication Critical patent/WO2001020004A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention provides human protein phosphatase and kinase proteins (PPHKP) and polynucleotides which identify and encode PPHKP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of PPHKP.
PCT/US2000/025515 1999-09-15 2000-09-14 Protein phosphatase and kinase proteins Ceased WO2001020004A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001523775A JP2003509053A (en) 1999-09-15 2000-09-14 Protein phosphatase and protein kinase
EP00968368A EP1212436A2 (en) 1999-09-15 2000-09-14 Protein phosphatase and kinase proteins
CA002383927A CA2383927A1 (en) 1999-09-15 2000-09-14 Protein phosphatase and kinase proteins
AU78297/00A AU7829700A (en) 1999-09-15 2000-09-14 Protein phosphatase and kinase proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15414199P 1999-09-15 1999-09-15
US60/154,141 1999-09-15

Publications (2)

Publication Number Publication Date
WO2001020004A2 WO2001020004A2 (en) 2001-03-22
WO2001020004A3 true WO2001020004A3 (en) 2001-10-18

Family

ID=22550173

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/025515 Ceased WO2001020004A2 (en) 1999-09-15 2000-09-14 Protein phosphatase and kinase proteins

Country Status (5)

Country Link
EP (1) EP1212436A2 (en)
JP (1) JP2003509053A (en)
AU (1) AU7829700A (en)
CA (1) CA2383927A1 (en)
WO (1) WO2001020004A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730491B2 (en) 2000-02-29 2004-05-04 Millennium Pharmaceuticals, Inc. 2504, 15977, and 14760, novel protein kinase family members and uses therefor
EP1212433A2 (en) * 1999-08-13 2002-06-12 Sugen, Inc. Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
EP1268818A2 (en) * 2000-03-24 2003-01-02 Millennium Pharmaceuticals, Inc. 18221, dual specificity phosphatase and uses thereof
CA2405725A1 (en) * 2000-04-10 2001-10-18 Merck Patent Gesellschaft Mit Beschraenkter Haftung Identification of a novel dual specificity phosphataes
US6461846B2 (en) * 2000-05-30 2002-10-08 Pe Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002020732A2 (en) * 2000-09-07 2002-03-14 Bayer Aktiengesellschaft Regulation of human map kinase phosphatase-like enzyme
US6825021B2 (en) * 2000-09-19 2004-11-30 Ceptyr, Inc. DSP-15 dual-specificity phosphatase
WO2002026997A2 (en) * 2000-09-26 2002-04-04 Ceptyr, Inc. Dsp-16 dual-specificity phosphatase
JP2004514434A (en) * 2000-11-20 2004-05-20 ピーイー　コーポレーション　（エヌワイ） Isolated human phosphatase protein, nucleic acid molecule encoding human phosphatase protein and uses thereof
MXPA03005436A (en) 2000-12-20 2004-05-05 Bristol Myers Squibb Co Polynucleotides encoding novel human phosphatases.
WO2005059123A2 (en) * 2003-12-16 2005-06-30 Ares Trading S.A. Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders
JP2010535503A (en) * 2007-08-10 2010-11-25 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ（エー＊エスティーエーアール） VHZ for cancer diagnosis and treatment
JP5756014B2 (en) 2008-08-08 2015-07-29 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ（エイ・スター） VHZ for cancer diagnosis and treatment
RU2425426C1 (en) * 2010-02-24 2011-07-27 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" Method for simulating mallory-weiss syndrome
JP6472075B2 (en) * 2015-02-26 2019-02-20 学校法人順天堂 Diagnosis of prognosis or resistance to treatment of GIST

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009199A2 (en) * 1997-08-20 1999-02-25 University Of Medicine And Dentistry Of New Jersey Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009199A2 (en) * 1997-08-20 1999-02-25 University Of Medicine And Dentistry Of New Jersey Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KUHEN K L ET AL: "Mechanism of interferon action Sequence of the human interferon-inducible RNA-dependent protein kinase (PKR) deduced from genomic clones", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES,GB,ELSEVIER SCIENCE PUBLISHERS, BARKING, vol. 178, no. 1, 31 October 1996 (1996-10-31), pages 191 - 193, XP004043360, ISSN: 0378-1119 *
MARTELL K J ET AL: "HVH-5: A PROTEIN TYROSINE PHOSPHATASE ABUNDANT IN BRAIN THAT INACTIVATES MITOGEN-ACTIVATED PROTEIN KINASE", JOURNAL OF NEUROCHEMISTRY,US,NEW YORK, NY, vol. 65, no. 4, 1995, pages 1823 - 1833, XP000196676, ISSN: 0022-3042 *
STONE S R ET AL: "THE NUCLEOTIDE SEQUENCE OF THE COMPLEMENTARY DNA ENCODING THE HUMAN LUNG PROTEIN PHOSPHATASE 2A-ALPHA CATALYTIC SUBUNIT", NUCLEIC ACIDS RESEARCH, vol. 16, no. 23, 1988, pages 11365, XP002160654, ISSN: 0305-1048 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7579148B2 (en) 2001-06-08 2009-08-25 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases
US7604936B2 (en) 2002-04-24 2009-10-20 Xdx, Inc. Methods and compositions for diagnosis and monitoring auto immune and chronic inflammatory diseases

Also Published As

Publication number Publication date
WO2001020004A2 (en) 2001-03-22
AU7829700A (en) 2001-04-17
CA2383927A1 (en) 2001-03-22
EP1212436A2 (en) 2002-06-12
JP2003509053A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
WO2001012662A3 (en) Membrane associated proteins
WO2000000610A3 (en) Human signal peptide-containing proteins
WO1999061471A3 (en) Human transmembrane proteins
WO2000015793A3 (en) Human gpcr proteins
WO2000022143A3 (en) Protein kinase homologs
WO2000021988A3 (en) Human ankyrin family protein
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO2000034477A3 (en) Neuron-associated proteins
WO1999058692A3 (en) Human apoptosis associated proteins
WO2001020004A3 (en) Protein phosphatase and kinase proteins
WO2000009709A3 (en) Proteases and associated proteins
WO2000026245A3 (en) Human membrane transport proteins
WO2000012703A3 (en) Protein transport-associated molecules
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2001005970A3 (en) Gtp-binding protein associated factors
WO2000014251A3 (en) Human transferase proteins
WO2001007612A3 (en) Receptors and associated proteins
WO2000052151A3 (en) Human secretory proteins
WO1999061614A3 (en) Human socs proteins
WO2000015770A3 (en) Human serine/threonine protein kinases
WO2001096546A3 (en) Protein phosphatases
WO2000028045A3 (en) Human hydrolase proteins
WO1999038981A3 (en) Human protein kinase molecules
WO2002010363A3 (en) Protein phosphatases
WO2000023589A3 (en) Proliferation and apoptosis related proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10070337

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2383927

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000968368

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 523775

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000968368

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000968368

Country of ref document: EP